The 20 Best Reticulohistiocytoma Doctors Near Me in Bronx, NY

Melissa Wasserstein is a Pediatrics provider practicing medicine in Bronx, New York. Dr. Wasserstein is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.

Jasmine Francis is an Oncologist practicing medicine in New York, New York. Dr. Francis is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Omar Abdel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Abdel is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Hairy Cell Leukemia (HCL), Leukemia, Rosai-Dorfman Disease, and Bone Marrow Aspiration. Dr. Abdel is currently accepting new patients.

Julia K. Gittler, MD, is an attending physician and Assistant Professor at Montefiore-Einstein. Dr. Gittler’s clinical areas of focus include all areas of pediatric dermatology, including eczema, vascular and other birthmarks, acne, genetic skin disorders and other pediatric dermatologic conditions. Dr. Gittler is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Congenital Herpes Simplex, TORCH Syndrome, Atopic Dermatitis, and Kerion Celsi.

Adnan Mir is a Pediatrics provider practicing medicine in Bronx, New York. Dr. Mir is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Giant Congenital Melanocytic Nevus, Necrotizing Granuloma, Proliferating Trichilemmal Cyst, and Basal Cell Skin Cancer.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Lisa Gennarini, MD, has been an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplantation at Children's Hospital at Montefiore (CHAM) since 2014. Her clinical focus is on treatment of children with leukemia and lymphoma as well as various vascular anomalies. She is also the CHAM Principal Investigator for Children?s Oncology Group trials, and also leads the CHAM Vascular Malformations Program. Dr. Gennarini graduated from Siena College in 2004, earning her Bachelor of Science in Biology. In 2008, she received her Doctor of Medicine at State University of New York, Upstate Medical University in Syracuse. She began a residency in Pediatrics at Jefferson Medical College/A.I. duPont Hospital for Children, followed by a fellowship in Pediatric Hematology/Oncology at Children?s Hospital at Montefiore. Dr. Gennarini's work on pediatrics, topics ranging from sickle cell disease to implementing communications skills training courses in pediatric hematology/oncology, has been published in various journals and books, and presented nationally. Dr. Gennarini is board certified by the American Board of Pediatrics in Pediatric Hematology/Oncology and General Pediatrics. Dr. Gennarini is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, Bone Marrow Aspiration, and Adenoidectomy.

Shyamala Navada is an Internal Medicine provider practicing medicine in Bronx, New York. Dr. Navada is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy.

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment. Dr. Satwani is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Anemia, Sickle Cell Disease, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant. Dr. Satwani is board certified in Pediatric Hematology-Oncology. Dr. Satwani is currently accepting new patients.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kahn is currently accepting new patients.

Adam Zimilover is a primary care provider, practicing in Infectious Disease in Bronx, New York. Dr. Zimilover is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. His clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

Christine T Lauren, MD, is an Associate Professor of Dermatology and Pediatrics at Columbia University Irving Medical Center and serves as an Associate Designated Institutional Official at New York-Presbyterian Hospital.She received her undergraduate degree from Cornell University and her medical degree from Columbia University’s College of Physicians and Surgeons, where she was elected to the Alpha Omega Alpha Honor Society. Dr. Lauren completed her pediatric residency at the Children’s Hospital of Philadelphia, where she served as chief resident, and returned to New York-Presbyterian Hospital, Columbia campus for her dermatology residency and pediatric dermatology fellowship. Dr. Lauren is board-certified in both dermatology and pediatrics. She is a fellow of the American Academy of Pediatrics and the American Academy of Dermatology, and an active member of the Society for Pediatric Dermatology and the Pediatric Dermatology Research Alliance. She currently serves on the executive committee of the American Academy of Pediatrics’ Section on Dermatology.Dr. Lauren’s clinical and academic interests include atopic dermatitis and other inflammatory skin conditions, vascular birthmarks, neonatal dermatology, and medical education. She is actively involved in clinical research and has authored numerous peer-reviewed publications and book chapters in both dermatology and pediatrics. She has been a strong advocate for medical training, previously serving as Program Director of the Dermatology Residency Program. In her current role as an Associate Designated Institutional Official at New York-Presbyterian Hospital, she supports graduate medical education across multiple specialties and campuses. Dr. Lauren is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses PHACE Syndrome, Hemangioma, Vascular Birthmark, and Atopic Dermatitis. Dr. Lauren is board certified in Pediatrics, Dermatology, and Pediatric Dermatology.

Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Erythroderma, and Tissue Biopsy. Dr. Gru is board certified in Anatomic Pathology, Dermatopathology, and Hematopathology.

George Niedt is a Dermatologist practicing medicine in New York, New York. Dr. Niedt is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 75 other conditions, according to our data. His clinical expertise encompasses Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Epidermoid Cyst.

Gustavo Maegawa is a Medical Genetics provider practicing medicine in New York, New York. Dr. Maegawa is rated as an Experienced provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Krabbe Disease, Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, and Gaucher Disease. Dr. Maegawa is board certified in Clinical Genetics And Genomics (MD) and Medical Biochemical Genetics. Dr. Maegawa is currently accepting new patients.

Jennifer Levine is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Levine is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, and Bone Marrow Aspiration.

Raajit Rampal is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Rampal is rated as a Distinguished provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rampal is currently accepting new patients.

Veronica Rotemberg is a Dermatologist practicing medicine in New York, New York. Dr. Rotemberg is rated as an Advanced provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Melanoma, and Actinic Keratosis.

Nitya Gulati is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Gulati is rated as a Distinguished provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Primary Mediastinal B-Cell Lymphoma (PMBCL). Dr. Gulati is currently accepting new patients.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as a Distinguished provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.